Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 60.39
(3.51%)
CNY 60.39
(3.51%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 898.63 Million CNY | 20.13% |
| 2022 | 688.12 Million CNY | 21.25% |
| 2021 | 567.5 Million CNY | 13.51% |
| 2020 | 499.96 Million CNY | 71.23% |
| 2019 | 291.98 Million CNY | -6.97% |
| 2018 | 313.85 Million CNY | 137.99% |
| 2017 | 131.87 Million CNY | 133.06% |
| 2016 | 56.58 Million CNY | 74.16% |
| 2015 | 32.48 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 192.47 Million CNY | -3.79% |
| 2024 Q1 | 128.15 Million CNY | -60.7% |
| 2024 Q2 | 195.15 Million CNY | 52.28% |
| 2023 Q4 | 326.09 Million CNY | 58.22% |
| 2023 FY | 826.62 Million CNY | 20.13% |
| 2023 Q1 | 150.09 Million CNY | -38.93% |
| 2023 Q2 | 172.39 Million CNY | 14.85% |
| 2023 Q3 | 206.1 Million CNY | 19.55% |
| 2022 Q4 | 245.78 Million CNY | 34.1% |
| 2022 FY | 688.12 Million CNY | 21.25% |
| 2022 Q2 | 150.29 Million CNY | 38.2% |
| 2022 Q1 | 108.75 Million CNY | -54.4% |
| 2022 Q3 | 183.28 Million CNY | 21.95% |
| 2021 Q1 | 106.26 Million CNY | -6.65% |
| 2021 Q4 | 238.5 Million CNY | 143.41% |
| 2021 FY | 567.5 Million CNY | 13.51% |
| 2021 Q3 | 97.98 Million CNY | -21.46% |
| 2021 Q2 | 124.75 Million CNY | 17.39% |
| 2020 Q1 | 74.4 Million CNY | -41.92% |
| 2020 FY | 499.96 Million CNY | 71.23% |
| 2020 Q2 | 142.12 Million CNY | 91.02% |
| 2020 Q3 | 167.75 Million CNY | 18.03% |
| 2020 Q4 | 113.83 Million CNY | -32.14% |
| 2019 Q3 | 17.02 Million CNY | -75.06% |
| 2019 FY | 291.98 Million CNY | -6.97% |
| 2019 Q4 | 128.11 Million CNY | 652.64% |
| 2019 Q2 | 68.24 Million CNY | -13.17% |
| 2019 Q1 | 78.59 Million CNY | -2.94% |
| 2018 Q4 | 80.98 Million CNY | 0.0% |
| 2018 FY | 313.85 Million CNY | 137.99% |
| 2017 FY | 131.87 Million CNY | 133.06% |
| 2016 FY | 56.58 Million CNY | 74.16% |
| 2015 FY | 32.48 Million CNY | 0.0% |